What is BRKR's market cap?

$9.72B, based on the Nov 4 close of $63.79.

Does Bruker pay a dividend?

Yes. The latest regular dividend was $0.05 per share (ex-date Sep 21), an annualised yield of 0.31%.

How much of BRKR is sold short?

12.7M shares, 11.4% of float, as of Oct 15, 2026.

What sector is BRKR in?

Healthcare, in the Lab Analytical Instruments industry.

NASDAQ · BRKRHealthcareLab Analytical Instruments

Bruker Corporation (BRKR)

$63.79+12.90%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$63.04▲ 62.85% in range

Nov 3, 2025Low $32.76 · High $64.75Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Bruker closed at $63.79 on Nov 4, up 12.90%, 1.5% below its 52-week closing high. Volume of 7.4M shares was 3.29× its 20-day average (well above normal).

Split-adjusted performance: +5.4% over one month, +50.8% over six months, +64.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $838.50M, up 5.2% from a year earlier, with a net margin of -7.5%.

Short interest was 12.7M shares at the Oct 15 settlement, up 2.2% from the prior report (11.4% of float, 5.7 days to cover).

Market cap$9.72B152.4M shares

Revenue · quarter$838.5M+5.2% YoY

Diluted EPS$-0.41−920.0% YoY

P/E · TTM—P/S 2.8×

Net margin-7.5%Gross 49.6%

Dividend yield0.31%$0.05 last paid

52-week range32.76 – 64.75−1.5% from high

Volume7.4M3.29× 20-day avg

Volatility · 60d56.5%Annualised

Short % of float11.4%5.7 days to cover

Net cash-$1.64BCash $184.9M

Next earnings—Not scheduled

Split-adjusted performance

1W +2.9%1M +5.4%3M +24.4%6M +50.8%YTD +35.4%1Y +64.8%3Y +16.2%5Y −17.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Lab Analytical Instruments

Percentile among 22 companies (100 = best)

6-month momentum75

Revenue growth53

Net margin67

Value (low P/E)—

Size67

Industry medians: 6-month return +33.8%, revenue growth +4.9%, net margin −19.0%, P/E 38.3×.

Short interest

Details →

Shares short12.7M+2.2% vs prior

Days to cover5.7Settled Oct 15

% of float11.4%

Short vol. 10d52.4%of daily volume

Closest peers by size in Lab Analytical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
BRKRBruker	$63.79	+12.90%	+50.8%	+5.2%	−7.5%	—	$9.72B
BIO.BBio-Rad Laboratories	$379.50	+4.22%	—	−0.1%	57.1%	45.6	$10.15B	Compare
BIOBio-Rad Laboratories	$379.99	+1.35%	+46.7%	−0.1%	57.1%	45.7	$10.16B	Compare
AVTRAvantor	$15.65	+0.38%	+85.6%	+4.6%	12.0%	31.4	$10.60B	Compare
TXG10x Genomics	$67.52	+3.42%	+196.9%	−12.6%	−11.9%	—	$8.80B	Compare
RVTYRevvity	$159.43	−2.48%	+60.9%	+1.3%	7.1%	74.9	$17.79B	Compare
ILMNIllumina	$226.54	−4.90%	+58.9%	+4.2%	19.5%	38.3	$34.25B	Compare
MTDMettler-Toledo International	$1,723.24	+1.48%	+29.9%	+4.5%	22.7%	38.1	$34.53B	Compare
WATWaters	$467.60	+1.67%	+33.8%	+113.4%	−8.3%	276.5	$45.94B	Compare

News about Bruker

All news →

Bruker Gains 66.3% in a Year: What's Driving the Rally?Zacks Investment Research · Oct 8, 2026Neutral Are Options Traders Betting on a Big Move in Bruker Stock?Zacks Investment Research · Oct 5, 2026▼ Negative Why Bruker (BRKR) is a Top Momentum Stock for the Long-TermZacks Investment Research · Oct 2, 2026▲ Positive

Quick answers

What does Bruker do?: Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) .
What is BRKR's market cap?: $9.72B, based on the Nov 4 close of $63.79.
Does Bruker pay a dividend?: Yes. The latest regular dividend was $0.05 per share (ex-date Sep 21), an annualised yield of 0.31%.
How much of BRKR is sold short?: 12.7M shares, 11.4% of float, as of Oct 15, 2026.
What sector is BRKR in?: Healthcare, in the Lab Analytical Instruments industry.

About Bruker

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

HQ: Billerica, MA11,085 employeesListed Aug 4, 2000bruker.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology